Arkolith/Insider Trading/GANX/Form 4

Richman Eric I

CHIEF EXECUTIVE OFFICER, DirectorGain Therapeutics, Inc. (GANX) · full profile →Form 4 · filed May 27, 2022
Net Buying
Open-Market Buys
$6K
Open-Market Sells
$0
Net Open-Market Flow
$6K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2022Buy(P)2K$2.58$6K218K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-005798) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML